Altered trafficking of mutant connexin32

S M Deschênes1, J L Walcott, T L Wexler

  • 1Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA.

Insights

X-linked Charcot-Marie-Tooth disease (CMTX) mutations disrupt connexin32 (Cx32) protein trafficking. This leads to toxic Cx32 accumulation in the cytoplasm, suggesting a shared disease mechanism in myelin disorders.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • X-linked Charcot-Marie-Tooth disease (CMTX) is a genetic peripheral neuropathy.
  • Connexin32 (Cx32) is a key protein in myelinating cells, and mutations are linked to CMTX.
  • Understanding Cx32 protein trafficking is crucial for elucidating CMTX pathophysiology.

Purpose of the Study:

  • To investigate the cellular localization of nine different Cx32 mutants associated with CMTX.
  • To determine how CMTX mutations affect Cx32 protein trafficking and cellular distribution.
  • To explore potential shared mechanisms in diseases affecting myelinating cells.

Main Methods:

  • Utilized communication-incompetent mammalian cells.
  • Examined the expression and localization of Cx32 mutants using immunofluorescence.
  • Assessed colocalization with cellular markers, such as the Golgi apparatus.

Main Results:

  • Identified three classes of Cx32 mutants based on cellular localization.
  • One class showed minimal Cx32 protein despite detectable mRNA.
  • Another class displayed Cx32 in the cytoplasm and at the cell surface (plaques/punctate staining).
  • A third class showed Cx32 restricted to the cytoplasm, often colocalizing with the Golgi apparatus.

Conclusions:

  • CMTX mutations predominantly impair Cx32 protein trafficking.
  • Mutations can lead to potentially toxic cytoplasmic accumulation of Cx32.
  • Shared pathophysiology may exist among diseases affecting myelinating cells, involving cytoplasmic accumulation of mutated proteins.